Zura Bio's skin disease drug fails mid-stage trial

Zura Bio's skin disease drug fails mid-stage trial

来源:Reuters发布于 2026-11-09

Zura Bio said on Monday its experimental drug failed the main goal of a mid-stage study in ​patients with hidradenitis suppurativa, a chronic skin disease ‌that causes painful lumps under the skin.

相关标的:ZURA

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。